The virus that causes COVID-19 today is not the same as the one that first sickened people way back in December 2019. Many of the variants circulating now are partially resistant to some of the antibody-based therapeutics that were developed based on the original virus. As the pandemic continues, more variants inevitably will arise, and the problem of resistance...
News
Scientists of the Institute of Chemistry of Additives of ANAS took part in the International Conference held in video format
On September 10-12, 2021, the 1st International Congress of Natural Sciences (ICNAS-2021) and the 1st International Symposium on Recent Achievements of Fundamental and Applied Sciences (ISFAS-2021) were organized by Ataturk University in Erzurum, Turkey. Young specialists of the Institute of Chemistry of Additives of ANAS Sabiya Osmanova, Konul Gahramanova, Gunay Ismayilova, Zubeyda Israfilova, Bahruz Safarov and others made reports...
News
Doctoral student of the Institute of Chemistry of Additives of ANAS will undergo an internship at the Lisbon University of Portugal
Ibadulla Mahmudov, a doctoral student of academician A.Guliyev Institute of Chemistry of Additives of the National Academy of Sciences of Azerbaijan will be sent for a six-month internship in Lisbon, Portugal, one of the leading universities in Europe in such fields of chemistry as synthesis and catalysis. According to the institute, doctoral student Ibadulla Makhmudov conducts scientific research in...
News
An article by scientists of the Institute of Chemistry of Additives of ANAS, dedicated to new types of stabilizers for polymer materials, has been published in a prestigious foreign...
Another article on the results of a study conducted by the scientists of the Institute of Chemistry of Additives (ICA) of the National Academy of Sciences of Azerbaijan (Academician V.Farzaliyev, Doctor of Chemical Sciences, Associate Professor A.Sujayev, leading researchers: Doctor of Philosophy in Technical Sciences T.Akchurina, Doctor of Philosophy on Chemistry, Associate Professor Kh.Efendiyeva and Doctor of Philosophy in...
News
The medicinal potential of new metal complexes obtained by scientists of the Institute of Chemistry of Additives of ANAS has been investigated
Scientists of Academician Ali Guliyev Institute of Chemistry of Additives of ANAS carried out a detailed analysis of the synthesized new metal complexes by the method of X-ray radiation, the theoretical and experimental mechanism of reactions was studied by computer calculations, to show the interaction of the complex with the enzyme by the method of "molecular docking" their pharmacokinetics...
Association seen in men and women for higher peanut consumption with reduced risks of total stroke, ischemic stroke, cardiovascular disease
FRIDAY, Sept. 10, 2021 (HealthDay News) -- For men and women in Japan, eating peanuts is associated with reduced risk of ischemic stroke and cardiovascular disease, according to a study published online Sept. 9 in Stroke.
Satoyo Ikehara, Ph.D., from the Osaka...
And this is just one of its properties. The Japanese edition of Yahoo News Japan told how much vinegar should be consumed daily to maintain health.
The author of the material Ketsuken shared his observations on the effects of vinegar on the body. It turns out that a small amount of this substance in the daily diet helps to normalize...
A study at the University of San Diego claims to have proof that COVID-19 is not a respiratory illness, but a vascular one.
This could explain blood clots in some COVID patients and other issues like "COVID feet", which are not classic symptoms of a respiratory illness.
The study, published in the journal Circulation Research, shows with precision how virus damages the...
Researchers with the University of Western Ontario have used a blood clotting enzyme called reptilase or batroxobin to create a glue that is so strong in its properties that it can stop bleeding in mere seconds.
Western University bioengineer Kibret Mequanint used the venom of the lancehead (Fer de Lance) snake (Bothrops atrox) to develop a body tissue adhesive that...
An international team of researchers from 13 countries has found that combination therapy with aspirin, statins (cholesterol-lowering drugs) and two drugs to correct blood pressure help reduce the risk of death from cardiovascular disease. Their work is published in The Lancet (https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01827-4/fulltext).
The scientists analyzed data from three clinical studies on 18 thousand patients from 26 countries who had no...










